Ghent University Academic Bibliography

Your filters: cql: author="Zhu, Chao" or (type any "bookEditor issueEditor" and editor="Zhu, Chao")

Add to list
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Yi Chao Foong, Daniel Merlo, Melissa Gresle, Katherine Buzzard, Dana Horakova, Eva Kubala Havrdova, Tomas Kalincik, Izanne Roos, Suzanne Hodgkinson, Jeannette Lechner-Scott, et al.

(2026) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 97(1). p.50-58
Add to list
- Journal Article
- A1
- open access
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Pakeeran Siriratnam, Saif Huda, Anneke Van der Walt, Paul Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, et al.

(2025) JOURNAL OF NEUROLOGY. 272(5).
Add to list
- Journal Article
- A1
- open access
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, Sifat Sharmin, Yi Chao Foong, Wei Zhen Yeh, Chao Zhu, Samia Joseph Khoury, Tunde Csepany, Barbara Willekens, et al.

(2025) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 96(4). p.361-369
Add to list
- Journal Article
- A2
- open access
Persistent progression independent of relapse activity in multiple sclerosis

Chao Zhu, Zhen Zhou, Tomas Kalincik, Izanne Roos, Katherine Buzzard, Olga Skibina, Raed Alroughani, Jens Kuhle, Marc Girard, Pierre Grammond, et al.

(2025) BRAIN COMMUNICATIONS. 7(5).
Add to list
Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD

Pakeeran Siriratnam, Saif Huda, Anneke van der Walt, Paul G. Sanfilippo, Sifat Sharmin, Yi Chao Foong, Wei Z. Yeh, Chao Zhu, Samia J. Khoury, Tunde Csepany, et al.

(2024) NEUROLOGY. 103(12).
Add to list
- Journal Article
- A1
- open access
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David Levitz, Yi Chao Foong, Paul Sanfilippo, Tim Spelman, Louise Rath, Angie Roldan, Anoushka Lal, Mastura Monif, Vilija Jokubaitis, Serkan Ozakbas, et al.

(2024) THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 17.
Add to list
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, et al.

(2023) JAMA NEUROLOGY. 80(7). p.739-748

Academic Bibliography

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Persistent progression independent of relapse activity in multiple sclerosis

Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG-positive NMOSD

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Contents

Support

Contact